Lucid Diagnostics (LUCD) Competitors $1.36 +0.06 (+4.23%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD vs. TMCI, NPCE, CLPT, SMLR, NNOX, SMTI, STIM, SNWV, ZIMV, and NVROShould you be buying Lucid Diagnostics stock or one of its competitors? The main competitors of Lucid Diagnostics include Treace Medical Concepts (TMCI), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), and Nevro (NVRO). These companies are all part of the "medical equipment" industry. Lucid Diagnostics vs. Treace Medical Concepts NeuroPace ClearPoint Neuro Semler Scientific Nano-X Imaging Sanara MedTech Neuronetics SANUWAVE Health ZimVie Nevro Treace Medical Concepts (NASDAQ:TMCI) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Do insiders & institutionals believe in TMCI or LUCD? 84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 27.7% of Treace Medical Concepts shares are held by insiders. Comparatively, 6.8% of Lucid Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor TMCI or LUCD? In the previous week, Treace Medical Concepts had 20 more articles in the media than Lucid Diagnostics. MarketBeat recorded 28 mentions for Treace Medical Concepts and 8 mentions for Lucid Diagnostics. Treace Medical Concepts' average media sentiment score of 0.12 beat Lucid Diagnostics' score of -0.22 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 5 Very Positive mention(s) 4 Positive mention(s) 18 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Lucid Diagnostics 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, TMCI or LUCD? Treace Medical Concepts has higher revenue and earnings than Lucid Diagnostics. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$210.82M1.95-$49.53M-$0.85-7.69Lucid Diagnostics$4.17M35.13-$52.67M-$1.34-1.01 Do analysts prefer TMCI or LUCD? Treace Medical Concepts presently has a consensus target price of $10.16, suggesting a potential upside of 55.31%. Lucid Diagnostics has a consensus target price of $3.50, suggesting a potential upside of 158.30%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Lucid Diagnostics is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is TMCI or LUCD more profitable? Treace Medical Concepts has a net margin of -30.33% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-30.33% -51.12% -26.36% Lucid Diagnostics -1,069.87%N/A -123.54% Which has more risk & volatility, TMCI or LUCD? Treace Medical Concepts has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Does the MarketBeat Community favor TMCI or LUCD? Lucid Diagnostics received 16 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 70.00% of users gave Lucid Diagnostics an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTreace Medical ConceptsOutperform Votes2644.07% Underperform Votes3355.93% Lucid DiagnosticsOutperform Votes4270.00% Underperform Votes1830.00% SummaryLucid Diagnostics beats Treace Medical Concepts on 10 of the 19 factors compared between the two stocks. Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCD vs. The Competition Export to ExcelMetricLucid DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$146.60M$4.53B$5.40B$8.49BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-1.1929.8226.7119.93Price / Sales35.1370.77395.44119.84Price / CashN/A51.0838.2534.62Price / Book-2.886.316.854.59Net Income-$52.67M$68.16M$3.23B$248.19M7 Day Performance5.86%21.03%5.35%2.21%1 Month Performance12.92%25.54%13.31%16.23%1 Year Performance48.95%22.21%17.58%8.00% Lucid Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCDLucid Diagnostics3.0528 of 5 stars$1.36+4.2%$3.50+158.3%+39.8%$146.60M$4.17M-1.1970TMCITreace Medical Concepts2.3204 of 5 stars$7.20+5.6%$10.16+41.1%+35.4%$452.81M$210.82M-7.27250Trending NewsNPCENeuroPace1.4895 of 5 stars$13.37+3.7%$15.20+13.7%+125.4%$437.91M$79.91M-13.37170Gap DownCLPTClearPoint Neuro1.7418 of 5 stars$13.64-3.3%$25.00+83.3%+108.6%$381.65M$31.39M-19.77110SMLRSemler Scientific2.5904 of 5 stars$34.84+0.1%$71.00+103.8%+78.4%$334.36M$56.29M7.10120Options VolumeGap UpHigh Trading VolumeNNOXNano-X Imaging1.4587 of 5 stars$5.56+6.1%$12.00+115.8%-43.7%$321.25M$11.28M-6.54190News CoverageUpcoming EarningsSMTISanara MedTech1.8016 of 5 stars$34.37+6.2%$48.50+41.1%-4.6%$305.48M$86.67M-34.7260Earnings ReportAnalyst RevisionHigh Trading VolumeSTIMNeuronetics1.9412 of 5 stars$4.14-6.5%$5.50+32.9%+69.6%$272.47M$74.89M-3.37180SNWVSANUWAVE HealthN/A$30.55+1.5%N/AN/A$261.17M$32.63M-6.7040ZIMVZimVie2.2685 of 5 stars$8.91+1.7%$19.50+118.9%-47.9%$248.12M$449.75M-0.682,700Positive NewsGap UpNVRONevro0.1973 of 5 stars$5.85+0.1%$5.36-8.3%-44.4%$224.32M$408.52M-3.091,090News Coverage Related Companies and Tools Related Companies TMCI Alternatives NPCE Alternatives CLPT Alternatives SMLR Alternatives NNOX Alternatives SMTI Alternatives STIM Alternatives SNWV Alternatives ZIMV Alternatives NVRO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LUCD Stock Free LUCD Stock Alerts